Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix/Influsplit SSW 2012/2013 immunogenicity and safety study in adults and elderly
2012-000789-39Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of Fluarix in influenza (2 arms), sponsored by GSK. Primary endpoint: Humoral immune response against each vaccine influenza strain. Started Apr 2012; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2012-000789-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000789-39.